Market revenue in 2023 | USD 117,074.0 million |
Market revenue in 2030 | USD 458,650.9 million |
Growth rate | 21.5% (CAGR from 2023 to 2030) |
Largest segment | Protac |
Fastest growing segment | PROTAC |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | PROTAC |
Key market players worldwide | Thermo Fisher Scientific Inc, Bio-Techne Corp, Promega, Merck KGaA, BPS Bioscience Inc., Bayer AG, BroadPharm, BOC Sciences |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account